Kenneth Ataga, MD

Dr. Ataga's clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.   Representative Publications: Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia Pharmacologic Therapies for Sickle Cell Disease Online profile